Prior Auth Required

81279 - JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) targeted sequence analysis

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / ServiceJAK2 (Janus kinase 2) (eg, myeloproliferative disorder) targeted sequence analysis
Procedure / Service Description

Genetic and Molecular Testing Medical Necessity Guideline - breakpoint region (MBR) and minor cluster region (mcr) breakpoints, qualitative or quantitative 81279 JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) targeted sequence analysis (eg, exons 12 and 13) 81283 FNL3 (interferon, lambda 3) (eg, drug response), gene analysis, rs12979860 variant

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.